← All trials
NCT05575687
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2022
- Primary completion
- Nov 30, 2023
- Completion date
- Nov 30, 2023
- First posted
- Oct 12, 2022
- Last posted
- Nov 16, 2022
- Enrollment
- 30
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wageningen UniversityLead sponsor
- Wageningen UniversityOverall official - principal investigator
- Wageningen UniversityReponsible party - principal investigator
- Tate & LyleCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.